Targeted Therapies in Oncology
April 2, 2022
Volume: 6
April 1, 2022
Volume: 11
Issue: 5
March 2022
Volume: 11
Issue: 4
February 2, 2022
Volume: 11
Issue: 3
February 1, 2022
Volume: 11
Issue: 2
January 2022
Volume: 11
Issue: 1
December 1, 2021
Volume: 10
Issue: 7
December 2, 2021
Volume: 10
Issue: 18
November 1, 2021
Volume: 1
Issue: 1
October 2, 2021
Volume: 10
Issue: 14
October 1, 2021
Volume: 10
Issue: 13
September 2021
Volume: 10
Issue: 12
August 2021
Volume: 10
Issue: 11
July 1 2021
Volume: 10
Issue: 9
July 2 2021
Volume: 10
Issue: 10
June 2021
Volume: 10
Issue: 8
May 2021
Volume: 10
Issue: 7
April 2, 2021
Volume: 10
Issue: 6
April 1, 2021
Volume: 10
Issue: 5
March 2021
February 2, 2021
Volume: 10
Issue: 3
February 1, 2021
Volume: 10
Issue: 2
January 2021
Volume: 10
Issue: 1
December 2, 2020
Volume: 9
Issue: 18
December 1 2020
Volume: 9
Issue: 17
November 2 2020
Volume: 9
Issue: 16
November 1 2020
Volume: 9
Issue: 15
October 2 2020
Volume: 9
Issue: 14
October 1, 2020
Volume: 9
Issue: 13
September 1 2020
Volume: 9
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
3
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
4
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
5
